NORTHERN TRUST CORP - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 110 filers reported holding INSYS THERAPEUTICS INC NEW in Q1 2018. The put-call ratio across all filers is 1.90 and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2019$1,685,000
+33.8%
364,716
+1.4%
0.00%
Q4 2018$1,259,000
-66.7%
359,697
-4.0%
0.00%
-100.0%
Q3 2018$3,776,000
+49.7%
374,626
+7.5%
0.00%0.0%
Q2 2018$2,522,000
+32.0%
348,334
+10.1%
0.00%
Q1 2018$1,911,000
-36.4%
316,325
+1.3%
0.00%
-100.0%
Q4 2017$3,003,000
+8.0%
312,227
-0.3%
0.00%0.0%
Q3 2017$2,781,000
-30.2%
313,211
-0.5%
0.00%0.0%
Q2 2017$3,983,000
+24.3%
314,825
+3.2%
0.00%0.0%
Q1 2017$3,205,000
+15.1%
304,919
+0.7%
0.00%0.0%
Q4 2016$2,785,000
-19.3%
302,786
+3.4%
0.00%0.0%
Q3 2016$3,451,000
-10.7%
292,719
-2.0%
0.00%0.0%
Q2 2016$3,865,000
-14.9%
298,672
+5.1%
0.00%
-50.0%
Q1 2016$4,543,000
-42.9%
284,098
+2.2%
0.00%
-33.3%
Q4 2015$7,961,000
+3.6%
278,037
+3.0%
0.00%0.0%
Q3 2015$7,681,000
-8.2%
269,887
+15.9%
0.00%0.0%
Q2 2015$8,367,000
+30.8%
232,940
+111.6%
0.00%
+50.0%
Q1 2015$6,399,000
+38.8%
110,086
+0.7%
0.00%
+100.0%
Q4 2014$4,611,000
+6.6%
109,374
-1.9%
0.00%0.0%
Q3 2014$4,325,000
+51.8%
111,530
+22.2%
0.00%0.0%
Q2 2014$2,850,000
-2.5%
91,257
+29.3%
0.00%0.0%
Q1 2014$2,924,000
+9.1%
70,591
+1.9%
0.00%0.0%
Q4 2013$2,681,000
+12.3%
69,272
+1.5%
0.00%0.0%
Q3 2013$2,387,000
+780.8%
68,225
+249.0%
0.00%
Q2 2013$271,00019,5460.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q1 2018
NameSharesValueWeighting ↓
Orbimed Advisors 6,171,440$54,802,0000.52%
Regal Investment Advisors LLC 161,600$1,435,0000.34%
Folger Hill Asset Management LP 396,315$3,519,0000.30%
SCHNEIDER CAPITAL MANAGEMENT CORP 181,900$1,615,0000.29%
Mirae Asset Global Investments Co., Ltd. 1,033,683$9,179,0000.17%
JW Asset Management, LLC 29,409$72,0000.05%
TCI Wealth Advisors, Inc. 9,516$85,0000.04%
GAM Holding AG 83,940$745,0000.03%
Freedom Investment Management, Inc. 63,032$560,0000.03%
Sterling Investment Advisors, Ltd. 5,000$44,0000.03%
View complete list of INSYS THERAPEUTICS INC NEW shareholders